Twist Bioscience Corporation has grown revenue 22% a year over three years and 28% a year over five. Revenue growth, 3-year annual rate: +22% (Diagnostics & Research median +8.4%). Revenue growth, 5-year rate: +28%, growth has slowed since the five-year average. Years of annual history on file: 9, FY2017 to FY2025, as filed.

TWSTTwist Bioscience Corporation

Healthcare

$159.83+473% 1Y

$159.83

$25.4552 weeks$204.94

Is it growing?

Good

Growing: revenue growing +19% year on year and operating margin widening (+5.9 points).

2 good, 1 without data

Revenue trend+19% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +28% a year.

Margin direction+5.9 points operating

Trailing-twelve-month operating margin, -33.5% now against -39.4% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is TWST growing?

Twist Bioscience Corporation has grown revenue 22% a year over three years and 28% a year over five.

+22%

Revenue growth, 3-year annual rate · Diagnostics & Research median +8.4% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +28%
Revenue growth, 5-year rate · +22% over three · growth has slowed since the five-year average
Years of annual history on file: 9
Years of annual history on file · FY2017 to FY2025, as filed

Details›